SEC ownership of Talis Biomedical Corp

Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001584751.

Comparable stake leader

Braden M. Leonard

Disclosed value leader

Braden M. Leonard

Comparable rows

0/15

Latest evidence

05 Sep 2024

Ownership snapshot CIK-linked ownership evidence from parsed SEC filings. 1 signal
Latest parsed ownership date
05 Sep 2024
Freshness: Most recent filing date in this holder set
Issuer Names, identifiers, and filing context for this profile. 2 identity fields
Issuer CIK
0001584751
Issuer location
Chicago, IL

Ownership snapshot

Top shareholders of Talis Biomedical Corp (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Braden M. Leonard
Disclosed value leader
Braden M. Leonard
Comparable rows
0/15
Latest evidence
05 Sep 2024
3/4/5 Highest disclosed value: $369,074 15 rows are not safely comparable across share classes. Showing 1-8 of 15 holder rows.

Quick read

Braden M. Leonard has the largest disclosed position value at $369.1K.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Braden M. Leonard's linked filing trail.
Disclosed position value Top 2
Braden M. Leonard $369.1K
Ramesh Ramakrishnan $168.6K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-8 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Braden M. Leonard
3/4/5
10%+ Owner
class O/S missing
$369,074
248,702 shares
05 Sep 2024
BAKER BROS. ADVISORS LP
3/4/5
Director, 10%+ Owner
class O/S missing
23,685 shares
09 Jun 2023
Ramesh Ramakrishnan
3/4/5
Former Officer
class O/S missing
$168,572
38,619 shares
13 Aug 2021
Brian J. Blaser
3/4/5
President and CEO, Director
mixed-class rows
1,375,000 shares
mixed-class rows
01 Dec 2021
Douglas Liu
3/4/5
Chief Operating Officer
class O/S missing
514,685 shares
02 Oct 2021
Robert J. Kelley
3/4/5
Chief Executive Officer, Director
class O/S missing
500,000 shares
07 Apr 2023
J. Roger Moody Jr.
3/4/5
Chief Financial Officer
class O/S missing
300,000 shares
07 Apr 2023
Kimberly J. Popovits
3/4/5
Director
class O/S missing
95,000 shares
09 Jun 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Forms 3/4/5 flow

Insider trading overview

Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 02 Aug 2025.

Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value Sell value
Shares: 0 Shares: 0
Window (months) Buy shares Sell shares Buy value Sell value Net value
0-3 0 0 $0 $0 $0
3-6 0 0 $0 $0 $0
6-9 0 0 $0 $0 $0
9-12 0 0 $0 $0 $0

Reporting owners

Insider holders from Forms 3/4/5

Showing 1-18 of 18 reporting-owner rows connected to Talis Biomedical Corp. Open a relationship link for the CIK-to-CIK filing trail.

Rows
18
Largest Forms 3/4/5 holder
Braden M. Leonard
Net 12M change
$0
Latest report
05 Sep 2024
Name Relationship Holdings Value Past Year Net Change Change % Valuation Report Date
Braden M. Leonard 10%+ Owner $369,074 Filing P/S 05 Sep 2024
Ramesh Ramakrishnan Former Officer $168,572 Mixed 13 Aug 2021
Patricia Ferrari Director Mixed 31 Jul 2024
BAKER BROS. ADVISORS LP Director, 10%+ Owner Mixed 09 Jun 2023
Kimberly J. Popovits Director Mixed 09 Jun 2023
Brian J. Blaser President and CEO, Director Mixed 01 Dec 2021
Robert J. Kelley Chief Executive Officer, Director Mixed 07 Apr 2023
Douglas Liu Chief Operating Officer Mixed 02 Oct 2021
Melissa Gilliam Director Mixed 09 Jun 2023
Rustem F. Ismagilov Director Mixed 09 Jun 2023
Rebecca Markovich Interim CFO Mixed 17 Jul 2023
Andrew A. Lukowiak President, Chief Scientific Officer Mixed 01 Aug 2023
Dr. Raymond Cheong Director Mixed 10 Mar 2023
Randal W. Scott Director Mixed 09 Jun 2023
J. Roger Moody Jr. Chief Financial Officer Mixed 07 Apr 2023
Matthew L. Posard Director Mixed 09 Jun 2023
Heinrich Dreismann Director Mixed 09 Jun 2023
John T. Young Jr. Director Mixed 31 Jul 2024

Recent insider transactions for Talis Biomedical Corp

Showing up to 300 recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % SEC-reported value SEC-reported price Shares Shares owned Date Ownership
No insider transactions were found in the last 12 months for this issuer.
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .